JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

NCT07510841 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Solid Cancers

Interventions

DRUG: JY016

Sponsor

Biotech Pharmaceutical Co., Ltd.